NSE · DRAGARWQ
Dr Agarwals Eye Hospital Limited
Historical price visualisation is temporarily undergoing corporate data-licensing maintenance. Full interactive price and chart data will return following our upcoming authorized NSE/BSE data-feed deployment. Derived metrics (valuation ratios, market-cap rank), company financials, shareholding, corporate actions, and mutual-fund holdings remain available.
Market cap rank
#1,119
of 5,096 stocks
▼ 161W
Peak #1,103 · 21 Sep 2026
Operating in Healthcare, Dr Agarwals Eye Hospital Limited generates a high return on equity, remains firmly promoter-controlled, with promoters holding 73%, and is growing revenue at a solid clip.
Market Cap
2,505.08 Cr
P/E Ratio
35.28
P/B Ratio
7.23
ROE
20.24%
ROCE
16.10%
Dividend Yield
0.08%
52W High
—
52W Low
—
Quarterly financials
| Metric | Q1 2026-27 | Q4 2025-26 | Q3 2025-26 | Q2 2025-26 |
|---|---|---|---|---|
| Revenue | 142.97 Cr | 120.01 Cr | 116.22 Cr | 117.72 Cr |
| Net Profit | 23.38 Cr | 16.24 Cr | 17.28 Cr | 19.32 Cr |
| EPS | 48.38 | 33.60 | 35.76 | 41.04 |
| Operating Profit | 33.73 Cr | 23.21 Cr | 25.48 Cr | 29.45 Cr |
Shareholding pattern
Promoter
72.67%
Public
27.33%
Mutual fund holdings
₹1.86
Cr total
4
Schemes
2
Fund Houses
₹1.86 Cr
Total Exposure
PGIM India Mutual Fund₹1.84 Cr (99.1%)
Motilal Oswal Mutual Fund₹0.02 Cr (0.9%)
Recent corporate actions
| Ex-Date | Type | Details |
|---|---|---|
| 02 Sep 2026 | Dividend | Dividend - Rs 4 Per Share |
Need this data in your app?
Full price history, technical indicators, and every field above via one REST API call.